Cargando…
Updates on the Systemic Treatment of Advanced Non-melanoma Skin Cancer
Non-melanoma skin cancers (NMSCs), which represent a diverse group of cutaneous malignancies, are the most common forms of human neoplasia. The incidence of these diseases is increasing due to a number of factors, including that of increasing human lifespans. The majority of NMSCs are basal cell car...
Autores principales: | Tanese, Keiji, Nakamura, Yoshio, Hirai, Ikuko, Funakoshi, Takeru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635480/ https://www.ncbi.nlm.nih.gov/pubmed/31355203 http://dx.doi.org/10.3389/fmed.2019.00160 |
Ejemplares similares
-
Imatinib mesylate in combination with pembrolizumab in patients with advanced KIT-mutant melanoma following progression on standard therapy: A phase I/II trial and study protocol
por: Hirai, Ikuko, et al.
Publicado: (2021) -
Nivolumab for advanced melanoma: pretreatment prognostic factors and early outcome markers during therapy
por: Nakamura, Yoshio, et al.
Publicado: (2016) -
Classic and new strategies for the treatment of advanced melanoma and non-melanoma skin cancer
por: Rubatto, Marco, et al.
Publicado: (2023) -
Anti-PD-1 antibody therapy for epithelial skin malignancies: An investigator-initiated, open-label, single-arm, multicenter, phase II clinical trial (NMSC-PD1 Study)
por: Ishii, Maki, et al.
Publicado: (2020) -
Dermoscopy of Melanoma and Non-melanoma Skin Cancers
por: Kato, Junji, et al.
Publicado: (2019)